These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 17175672)
41. Spirometry for the diagnosis of airway obstruction in patients with risk factors for COPD: the GOLD and lower limit of normal criteria. Grafino M; Todo-Bom F; Lutas AC; Cabral J; Pereira M; Valença J; Furtado ST J Bras Pneumol; 2022; 47(6):e20210124. PubMed ID: 35019054 [TBL] [Abstract][Full Text] [Related]
43. Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation. Murphy DE; Panos RJ Int J Chron Obstruct Pulmon Dis; 2013; 8():199-208. PubMed ID: 23637527 [TBL] [Abstract][Full Text] [Related]
44. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality. Mannino DM; Diaz-Guzman E Chest; 2012 Jan; 141(1):73-80. PubMed ID: 21659434 [TBL] [Abstract][Full Text] [Related]
45. Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals. Rode L; Bojesen SE; Weischer M; Vestbo J; Nordestgaard BG Thorax; 2013 May; 68(5):429-35. PubMed ID: 23268483 [TBL] [Abstract][Full Text] [Related]
46. Prevalence of obstructive lung disease in an African country using definitions from different international guidelines: a community based cross-sectional survey. Pefura-Yone EW; Kengne AP; Balkissou AD; Magne-Fotso CG; Ngo-Yonga M; Boulleys-Nana JR; Efe-de-Melingui NR; Ndjeutcheu-Moualeu PI; Mbele-Onana CL; Kenmegne-Noumsi EC; Kolontchang-Yomi BL; Theubo-Kamgang BJ; Ebouki ER; Djuikam-Kamga CK; Amougou F; Mboumtou L; Petchou-Talla EL; Kuaban C; BMC Res Notes; 2016 Feb; 9():124. PubMed ID: 26917543 [TBL] [Abstract][Full Text] [Related]
47. Six-second spirometry for detection of airway obstruction: a population-based study in Austria. Lamprecht B; Schirnhofer L; Tiefenbacher F; Kaiser B; Buist SA; Studnicka M; Enright P Am J Respir Crit Care Med; 2007 Sep; 176(5):460-4. PubMed ID: 17556719 [TBL] [Abstract][Full Text] [Related]
48. Comparison of NHANES III and ERS/GLI 12 for airway obstruction classification and severity. Linares-Perdomo O; Hegewald M; Collingridge DS; Blagev D; Jensen RL; Hankinson J; Morris AH Eur Respir J; 2016 Jul; 48(1):133-41. PubMed ID: 27288032 [TBL] [Abstract][Full Text] [Related]
49. Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality. Martinez CH; Mannino DM; Jaimes FA; Curtis JL; Han MK; Hansel NN; Diaz AA Ann Am Thorac Soc; 2015 Dec; 12(12):1788-95. PubMed ID: 26524488 [TBL] [Abstract][Full Text] [Related]
50. COPD prevalence in a random population survey: a matter of definition. Shirtcliffe P; Weatherall M; Marsh S; Travers J; Hansell A; McNaughton A; Aldington S; Muellerova H; Beasley R Eur Respir J; 2007 Aug; 30(2):232-9. PubMed ID: 17666557 [TBL] [Abstract][Full Text] [Related]
51. Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study. Çolak Y; Marott JL; Vestbo J; Lange P COPD; 2015 Feb; 12(1):5-13. PubMed ID: 25290888 [TBL] [Abstract][Full Text] [Related]
52. Airflow limitation by the Global Lungs Initiative equations in a cohort of very old adults. Turkeshi E; Vaes B; Andreeva E; Matheï C; Adriaensen W; Van Pottelbergh G; Degryse JM Eur Respir J; 2015 Jul; 46(1):123-32. PubMed ID: 25882799 [TBL] [Abstract][Full Text] [Related]
53. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Adeloye D; Song P; Zhu Y; Campbell H; Sheikh A; Rudan I; Lancet Respir Med; 2022 May; 10(5):447-458. PubMed ID: 35279265 [TBL] [Abstract][Full Text] [Related]
54. COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers. Akkermans RP; Biermans M; Robberts B; ter Riet G; Jacobs A; van Weel C; Wensing M; Schermer T Eur Respir J; 2014 Jan; 43(1):54-63. PubMed ID: 23563262 [TBL] [Abstract][Full Text] [Related]
55. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Vandevoorde J; Verbanck S; Schuermans D; Kartounian J; Vincken W Chest; 2005 May; 127(5):1560-4. PubMed ID: 15888828 [TBL] [Abstract][Full Text] [Related]
56. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Miller MR; Quanjer PH; Swanney MP; Ruppel G; Enright PL Chest; 2011 Jan; 139(1):52-9. PubMed ID: 20522571 [TBL] [Abstract][Full Text] [Related]
57. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study. Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413 [TBL] [Abstract][Full Text] [Related]
58. The impact of heart failure on the classification of COPD severity. Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080 [TBL] [Abstract][Full Text] [Related]
59. Prevalence and determinants of airflow limitation in urban and rural children exposed to cooking fuels in South-East Nigeria. Oguonu T; Obumneme-Anyim IN; Eze JN; Ayuk AC; Okoli CV; Ndu IK Paediatr Int Child Health; 2018 May; 38(2):121-127. PubMed ID: 29542392 [TBL] [Abstract][Full Text] [Related]
60. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort. van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J; Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]